July 3, 2014 / 2:18 PM / 3 years ago

BUZZ-Tekmira Pharmaceuticals Corp: FDA puts early-stage study on hold

July 3 (Reuters) - ** Canadian drug developer’s U.S.-listed shares down 17.5 pct at $11.38

** The U.S. Food and Drug Administration places on hold an early-stage study testing the company’s experimental ebola drug in healthy volunteers

** FDA has asked for an amended protocol and additional data related to higher doses of the drug, Tekmira said

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below